Results 31 to 40 of about 12,776,407 (326)

Efficacy and safety of low-dose aspirin combined with low-molecular-weight heparin in treatment of preeclampsia: a meta-analysis and systematic review

open access: yesArchives of Medical Science, 2021
Introduction The role of low-dose aspirin combined with low-molecular-weight heparin (LMWH) in the treatment of preeclampsia (PE) remains unclear. We aimed to assess the efficacy and safety of low-dose aspirin combined with LMWH in PE treatment, to ...
Chunfeng Wu   +3 more
doaj   +1 more source

Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D).

open access: yesJournal of Clinical Oncology, 2018
Purpose Venous thromboembolism (VTE) is common in patients with cancer. Long-term daily subcutaneous low molecular weight heparin has been standard treatment for such patients.
A. Young   +17 more
semanticscholar   +1 more source

Impact of pharmaceutical care on self-administration of outpatient low-molecular-weight heparin therapy [PDF]

open access: yes, 2014
Outpatient subcutaneous (s.c.) therapies are becoming more and more common in the treatmentof different diseases. The effectiveness of community-pharmacy-based interventions in preventingproblems that arise during s.c.
Kurt E. Hersberger   +13 more
core   +1 more source

Comparison of Low-Molecular-Weight Heparins Prepared From Ovine Heparins With Enoxaparin

open access: yesClinical and Applied Thrombosis/Hemostasis, 2019
Heparin and its low-molecular-weight heparin derivatives are widely used clinical anticoagulants. These drugs are critical for the practice of medicine in applications, including kidney dialysis, cardiopulmonary bypass, and in the management of venous ...
Jianle Chen BS   +13 more
doaj   +1 more source

Low-molecular-weight heparin significantly reduces embolization after carotid endarterectomy: a randomized controlled trial.

open access: yes, 2007
Low-molecular-weight heparin significantly reduces embolization after carotid endarterectomy: a randomized controlled ...
C.I. Jones (7579295)   +4 more
core   +6 more sources

Preliminary Experience With Low Molecular Weight Heparin Strategy in COVID-19 Patients

open access: yesFrontiers in Pharmacology, 2020
Background Heparin administration in COVID-19 patients is recommended by expert consensus, although evidence about dosage, duration and efficacy are limited. We aim to investigate the association between different dosages of low molecular weight heparin (
P. Paolisso   +13 more
semanticscholar   +1 more source

Cost-effectiveness of mechanical thromboprophylaxis for cesarean deliveries in Brazil.

open access: yesPLoS ONE, 2023
ObjectiveTo evaluate the cost-effectiveness of using mechanical thromboprophylaxis for patients undergoing a cesarean delivery in Brazil.MethodsA decision-analytic model built in TreeAge software was used to compare the cost and effectiveness of ...
Alex Veloz   +4 more
doaj   +3 more sources

The anti-cancer properties of heparin and its derivatives: a review and prospect

open access: yesCell Adhesion & Migration, 2020
Heparin, including unfractionated heparin (UFH), low-molecular-weight heparin (LMWH) and heparin derivatives, are commonly used in venous thromboembolism treatment and reportedly have beneficial effects on cancer survival.
Sai-Nan Ma   +8 more
doaj   +1 more source

Plasma free fatty acid levels influence Zn2+-dependent histidine-rich glycoprotein-heparin interactions via an allosteric switch on serum albumin [PDF]

open access: yes, 2014
Background: Histidine-rich glycoprotein (HRG) regulates coagulation, through its ability to bind and neutralize heparins. HRG associates with zinc ions (Zn2+) to stimulate HRG-heparin complex formation. Under normal conditions the majority of plasma Zn2+
Schwarz-Linek, Ulrich   +4 more
core   +1 more source

Outpatient subcutaneous injection therapy : drug use problems with low-molecular-weight heparins and impact of pharmaceutical care [PDF]

open access: yes, 2012
Arterial and venous thromboses are important diseases associated with significant morbidity, mortality, and costs. To date, the orally taken vitamin K antagonists are, together with the parenterally administered heparins, still the most frequently used ...
Mengiardi, Seraina
core   +1 more source

Home - About - Disclaimer - Privacy